Dr. Han is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Gresham Dr
Suite 1100
Norfolk, VA 23507Phone+1 757-388-6200Fax+1 757-388-6201
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Otolaryngology - Head and Neck Surgery, 1998 - 2002
- MCP-Hahnemann College of MedicineClass of 1997
Certifications & Licensure
- OR State Medical License 2002 - Present
- VA State Medical License 2003 - 2026
- WI State Medical License 1998 - 2003
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Most Compassionate Doctor American Registry
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps Start of enrollment: 2013 Jan 01
- Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS Start of enrollment: 2017 Apr 20
Publications & Presentations
PubMed
- 402 citationsInternational consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, Benjamin S. Bleier, Adam S. DeConde
International Forum of Allergy & Rhinology. 2021-03-01 - 14 citationsThe HIRA histone chaperone complex subunit UBN1 harbors H3/H4- and DNA-binding activity.M. Daniel Ricketts, Nirmalya Dasgupta, Jiayi Fan, Joseph Han, Morgan Gerace
The Journal of Biological Chemistry. 2019-06-07 - 604 citationsEfficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multi...Claus Bachert, Joseph K. Han, Martin Desrosiers, Peter Hellings, Nikhil Amin
Lancet. 2019-11-02
Press Mentions
- AstraZeneca Plc Tezspire Meets Primary Endpoints in WAYPOINT TrialNovember 8th, 2024
- TEZSPIRE Met Both Co-Primary Endpoints in the Phase III WAYPOINT Trial in Patients with Chronic Rhinosinusitis with Nasal PolypsNovember 8th, 2024
- New 12-Month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve CollapseSeptember 6th, 2022
- Join now to see all
Committees
- Member, Guideline Development Panel, American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) 2015 - Present
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: